PROM1 and hepatocellular carcinoma: We also cultured patient‐derived HCC organoids on this same setup and found softer support to promote HCC cell proliferation, migration, invasion, CD133 expression, and the ability to resist 5‐FU chemotherapy compared to stiffer support (Figure 6C–E).